- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07616596
Gaze Stabilization vs Oculomotor Exercises on Cybersickness in Computer Users (GAZE-CS)
Effectiveness of Gaze Stabilization Exercises Versus Oculomotor Exercises on Cybersickness in Computer Users: A Randomized Clinical Trial
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
This is a single-blinded, randomized clinical trial. Participants (n=46) will be recruited from The University of Faisalabad. Inclusion criteria include screen time >6 hours/day, computer usage for at least 10 years, and a Simulator Sickness Questionnaire (SSQ) score between 20 and 40.
Group A (Intervention): Gaze Stabilization Exercises. Week 1: View X1 exercises. Week 2: View X2 exercises. Week 3: Gaze shift exercises. Week 4: Imaginary Target exercises. (3 sessions/week, 1 minute per exercise, 3 times each).
Group B (Active Comparator): Oculomotor Exercises. Week 1: Range exercises. Week 2: Saccadic exercises. Week 3: Pursuit exercises. Week 4: Vergence exercises. (3 sessions/week, 1 minute per exercise, 3 times each).
Outcomes: The primary outcome is the change in Dynamic Visual Acuity (LogMAR scale) and Cybersickness (SSQ score). The secondary outcome is Quality of Life (SF-36 questionnaire). Measurements will be taken at baseline, Week 2, and Week 4. Data will be analyzed using SPSS version 20.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Punjab Province
-
Faisalābad, Punjab Province, Pakistan, 3800
- The University of Faisalabad
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Screen time > 6 hours per day
- Computer usage history of at least 10 years
- Complaints of vertigo, blurred vision, and nausea during computer usage
- Positive Romberg's test
- Abnormal VOR (4-6 lines lost on LogMAR scale)
- SSQ score between 20 and 40
Exclusion Criteria:
- Diagnosed vestibular disorders (e.g., BPPV, Meniere's)
- History of falls in the past 6 months
- Pregnancy
- Any neurological or neurodegenerative disease
- Use of walking aids
- Severe visual impairments (worse than 6/12 on Snellen)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Gaze Stabilization Exercises
Participants in this arm will receive Gaze Stabilization Exercises (GSE) for 4 weeks, 3 sessions per week.
The protocol includes View X1, View X2, Gaze Shift, and Imaginary Target exercises.
Each exercise is performed for 1 minute, repeated 3 times per session.
Exercises target the vestibulo-ocular reflex (VOR) by coordinating head and eye movements to reduce sensory conflict.
|
Week 1 - View X1: Patient sits upright.
Target held at eye level 1 meter away.
Patient turns head horizontally (left/right) or vertically (up/down) while keeping eyes fixed on target.
Speed: slow (1Hz).
Duration: 1 minute.
Repetitions: 3 times per direction.
Week 2 - View X2: Same as View X1 but head movement speed increased to 2Hz.
Week 3 - Gaze Shift: Two targets placed 30 cm apart horizontally or vertically.
Patient rotates head to face Target 1, then shifts gaze to Target 2 while continuing head rotation toward Target 2. Duration: 1 minute.
Repetitions: 3 times.
Week 4 - Imaginary Target: Patient fixates on a target (e.g., a sticker on wall).
Closes eyes.
Rotates head 30-45 degrees away from target.
While eyes closed, patient imagines still looking at target.
Opens eyes and checks if fixation is accurate.
Duration: 1 minute.
Repetitions: 3 times per direction.
All exercises are performed under supervision for the first 3 sessions, then home-based with weekly follow-up calls.
|
|
Actieve vergelijker: Oculomotor Exercises Group
Participants in this arm will receive Oculomotor Exercises for 4 weeks, 3 sessions per week.
The protocol includes Range, Saccadic, Pursuit, and Vergence exercises.
Each exercise is performed for 1 minute, repeated 3 times per session.
Exercises target isolated eye movements without head motion to improve oculomotor control and reduce visual strain.
|
Week 1 - Range Oculomotor Exercises: Eyes closed.
Patient moves eyes slowly in horizontal (left-right), vertical (up-down), diagonal (top-left to bottom-right), and rotational (clockwise/counterclockwise) directions.
Duration: 1 minute per direction.
Repetitions: 3 times.
Week 2 - Saccadic Exercises: Two stationary targets (e.g., two fingers) held 30 cm apart at eye level.
Patient rapidly shifts gaze between targets without moving head.
Duration: 1 minute.
Repetitions: 3 times.
Week 3 - Pursuit Exercises: A single target (e.g., pen) is moved slowly horizontally and vertically.
Patient follows target smoothly with eyes only (head still).
Speed: approx 20 degrees/second.
Duration: 1 minute per direction.
Repetitions: 3 times.
Week 4 - Vergence Exercises: Target (e.g., pen) starts at 50 cm from patient's nose.
Patient focuses on target as it is slowly moved toward nose to 5 cm (convergence), then back to 50 cm (divergence).
Duration: 1 minute.
Repetitions: 3 times under supervision.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Vestibulo-Ocular Reflex (VOR) Function
Tijdsspanne: Baseline (Week 0), Week 2, Week 4
|
Measured by Dynamic Visual Acuity (DVA) test using a LogMAR chart.
Patient reads smallest line possible while head is stationary (static VA).
Then patient rotates head horizontally at 2Hz while reading.
Number of lines lost between static and dynamic conditions is recorded.
Normal VOR: 1-2 lines lost.
Abnormal: 4-6 lines lost.
Higher lines lost = worse VOR function.
|
Baseline (Week 0), Week 2, Week 4
|
|
Change in Cybersickness Severity
Tijdsspanne: Baseline (Week 0), Week 2, Week 4
|
Measured by the Simulator Sickness Questionnaire (SSQ).
Contains 16 symptoms rated 0-3 (0=not at all, 3=severe).
Total score range 0-48.
Subscales: Nausea (symptoms 1,2,6,7,8,9,14,15), Oculomotor (3,4,5,10,11,12,13), and Disorientation (5,10,11,12,13,14,15).
Higher score = worse cybersickness.
|
Baseline (Week 0), Week 2, Week 4
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Quality of Life
Tijdsspanne: Baseline (Week 0), Week 4
|
Measured by the Short Form-36 (SF-36) Health Survey.
Contains 36 items measuring 8 domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, Mental Health.
Scores transformed to 0-100 scale per domain.
Higher score = better quality of life.
|
Baseline (Week 0), Week 4
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- TUF/EIRB/ 211 /26
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Vestibulaire ziekten
-
University of PennsylvaniaVoltooidPatiënten met primaire of secundaire diagnose Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Behalve wanneer het 5e cijfer 2 was)Verenigde Staten
-
SpringWorks Therapeutics, Inc., a healthcare company...VerkrijgbaarNeurofibromatose Type 1-geassocieerde plexiforme neurofibromen | Histiocytisch neoplasma | Andere MAP-K Pathway Driven Diseases
Klinische onderzoeken op Gaze Stabilization Exercises
-
Riphah International UniversityVoltooidPosturale lage rugpijnPakistan
-
Istanbul Medipol University HospitalActief, niet wervendPlantaire fasciitis van beide voetenKalkoen